Vivek Rai

3.2k total citations · 1 hit paper
29 papers, 2.3k citations indexed

About

Vivek Rai is a scholar working on Clinical Biochemistry, Molecular Biology and Immunology. According to data from OpenAlex, Vivek Rai has authored 29 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Biochemistry, 15 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Vivek Rai's work include Advanced Glycation End Products research (17 papers), Glycosylation and Glycoproteins Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Vivek Rai is often cited by papers focused on Advanced Glycation End Products research (17 papers), Glycosylation and Glycoproteins Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Vivek Rai collaborates with scholars based in India, United States and Germany. Vivek Rai's co-authors include Sutapa Bose, Rashmi Ray, Sumanta Ray, Ann Marie Schmidt, Alexander Shekhtman, David S. Burz, Judyta K. Juranek, Sergey Reverdatto, Anamika Shrivastava and Surjit Singh and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Vivek Rai

29 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond

2013 397 citations Sutapa Bose, Vivek Rai et al. profile →

Peers

Countries citing papers authored by Vivek Rai

Since Specialization

Citations

This map shows the geographic impact of Vivek Rai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Rai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Rai more than expected).

Fields of papers citing papers by Vivek Rai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Rai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Rai. The network helps show where Vivek Rai may publish in the future.

Co-authorship network of co-authors of Vivek Rai

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Rai. A scholar is included among the top collaborators of Vivek Rai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Rai. Vivek Rai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atx regulates skeletal muscle regeneration via LPAR1 and promotes hypertrophy 2021 ·Cell Reports ·Rashmi Ray, (unknown), Vassilis Aidinis, Vivek Rai	14
2	p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment 2021 ·Cell Death and Disease ·(unknown), Satyendra Kumar Singh, (unknown), Rashmi Ray, Vivek Rai	17
3	MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment 2020 ·Medical Oncology ·Satyendra Kumar Singh, (unknown), (unknown), (unknown), Rashmi Ray, Vivek Rai	14
4	Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment 2020 ·Cell Communication and Signaling ·Rashmi Ray, (unknown), Satyendra Kumar Singh, (unknown), Vivek Rai	18
5	Molecular Imaging of RAGE Expression in Human Glioblastoma 2019 ·(unknown), (unknown), Qing Li, Rashmi Ray, Vivek Rai, (unknown), Lynne L. Johnson	1
6	Cysteine mediated disulfide bond formation in RAGE V domain facilitates its functionally relevant dimerization 2018 ·Biochimie ·(unknown), Rashmi Ray, (unknown), (unknown), Satyendra Kumar Singh, (unknown), Narottam Acharya, Vivek Rai	3
7	Evaluation of HDPE and LDPE degradation by fungus, implemented by statistical optimization 2017 ·Scientific Reports ·Nupur Ojha, Neha Pradhan, Surjit Singh, Anil Barla, Anamika Shrivastava, (unknown), Vivek Rai, Sutapa Bose	240
8	Lysophosphatidic acid converts monocytes into macrophages in both mice and humans 2017 ·Blood ·Rashmi Ray, Vivek Rai	86
9	Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction 2016 ·Scientific Reports ·Michaele B. Manigrasso, (unknown), Vivek Rai, Jinghua Zhang, Sergey Reverdatto, Nosirudeen Quadri, Robert J. DeVita, Ravichandran Ramasamy, Alexander Shekhtman, Ann Marie Schmidt	92
10	Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling 2016 ·Structure ·Jing Xue, Michaele B. Manigrasso, Matteo Scalabrin, Vivek Rai, Sergey Reverdatto, David S. Burz, Daniele Fabris, Ann Marie Schmidt, Alexander Shekhtman	50
11	Treatment effect with anti-RAGE F(ab′)₂ antibody improves hind limb angiogenesis and blood flow in Type 1 diabetic mice with left femoral artery ligation 2015 ·Vascular Medicine ·(unknown), (unknown), Qing Li, Rashmi Ray, Vivek Rai, Geping Zhang, Ann Marie Schmidt, Lynne L. Johnson	13
12	RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis 2015 ·Neuroscience & Biobehavioral Reviews ·Rashmi Ray, Judyta K. Juranek, Vivek Rai	118
13	Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells 2013 ·PLoS ONE ·Sergey Reverdatto, Vivek Rai, Jing Xue, David S. Burz, Ann Marie Schmidt, Alexander Shekhtman	23
14	RAGE binds C1q and enhances C1q-mediated phagocytosis 2012 ·Cellular Immunology ·Wanchao Ma, Vivek Rai, Barry I. Hudson, Fei Song, Ann Marie Schmidt, Gaetano R. Barile	56
15	Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling 2012 ·The Journal of Experimental Medicine ·Vivek Rai, Fatouma Touré, Seth Chitayat, Renjun Pei, Fei Song, Qing Li, Jinghua Zhang, Rosa Rosario, Ravichandran Ramasamy, Walter Chazin, Ann Marie Schmidt	98
16	Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) 2011 ·Journal of Biological Chemistry ·Vivek Rai, Andres Y. Maldonado, David S. Burz, Sergey Reverdatto, Ann Marie Schmidt, Alexander Shekhtman	102
17	Advanced Glycation End Product Recognition by the Receptor for AGEs 2011 ·Structure ·Jing Xue, Vivek Rai, David Singer, (unknown), Jingjing Xie, Sergey Reverdatto, David S. Burz, (unknown), Ralf Hoffmann, Alexander Shekhtman	175
18	Activation of the ROCK1 Branch of the Transforming Growth Factor-β Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice 2010 ·Circulation Research ·De-xiu Bu, Vivek Rai, Xiaoping Shen, Rosa Rosario, Yan Lü, Vivette D. D’Agati, Shi Fang Yan, Richard A. Friedman, (unknown), Ann Marie Schmidt	76
19	Evidence for Inhibitory Interaction of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae Hyaluronidase 2008 ·Journal of Biological Chemistry ·Gitanjali Yadav, (unknown), Babal K. Jha, Vivek Rai, Vinod Bhakuni, Kasturi Datta	16
20	Translocation of metals in pea plants grown on various amendment of electroplating industrial sludge 2007 ·Bioresource Technology ·Sutapa Bose, (unknown), Vivek Rai, A. K. Bhattacharyya, AL. Ramanathan	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact